Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Lovalekar TusharVP, Information Technology | Option exercise | M | — 85 sh | Jan 6, 2026 |
| 9 | Altamura Michelle VervaisEVP, General Counsel, Sec. | Option exercise | M | — 1,214 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Lovalekar TusharVP, Information Technology | Grant or award | A | — 316 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Bunker Mathew BSENIOR VP, OPERATIONS | Grant or award | A | — 68 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Sparks Paul EugeneDirector | Grant or award | A | — 18.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Rayphole Robert P.VP CAO & Controller | Tax withholding | F | $8,166 322 sh | Jan 6, 2026 traded Jan 4, 2026 |
| 9 | Duty StuartDirector | Grant or award | A | — 40.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Xia YuDirector | Grant or award | A | — 35.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT | Grant or award | A | — 1,730 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Park Angie YChief Financial Officer | Grant or award | A | $28K 105 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 9 | Manji HusseiniDirector | Grant or award | A | $50K 4,228 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT | Grant or award | A | — 1,730 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Tunnicliff Max HughesCFO and Senior EVP | Grant or award | A | — 28.8K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Heitz Michael JohnChief Financial Officer | Tax withholding | F | $14K 414 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Arntzen Christopher JSVP, GC & Secretary | Grant or award | A | — 7,488 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 9 | Barrocas MarkDirector, Chief Executive Officer | Grant or award | A | — 158.8K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $36K 177 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $33K 161 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $18K 86 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 7 | Lin MarkEVP and CFO | Option exercise · 10b5-1 plan | M | — 3,164 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 7 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $381K 1,659 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 7 | Singh VikasEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 3,980 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 7 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $295K 1,292 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 6 | Lin MarkEVP and CFO | Tax withholding · 10b5-1 plan | F | $88K 1,198 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 6 | Sieffert Kristen NPresident | Open-market sale · 10b5-1 plan | SELL | $18K 750 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Ribeiro RamiroChief Medical Officer | Grant or award | A | — 85.7K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Ribeiro RamiroChief Medical Officer | Option exercise | M | — 19.7K sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | Olsson ShawnChief Commercial Officer | Grant or award | A | — 14.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Cowan ChadChief Scientific Officer | Tax withholding | F | $1,603 1,611 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Krupka Devin MController, PAO | Option exercise | M | — 352 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | Fitzpatrick JenniferChief Legal Officer | Grant or award | A | — 103.1K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Krupka Devin MController, PAO | Tax withholding | F | $1,692 119 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | Ribeiro RamiroChief Medical Officer | Grant or award | A | — 171.4K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Krupka Devin MController, PAO | Option exercise | M | — 352 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | O'Connor John TerryGeneral Counsel | Grant or award | A | — 15.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Olsson ShawnChief Commercial Officer | Grant or award | A | — 84.2K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 3 | Kelleher Eric RobertSee Remarks | Derivative conversion · 10b5-1 plan | C | — 2,409 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 3 | Spice Adam C.Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 731.3K sh | Jan 6, 2026 traded Jan 5, 2026 |
| 3 | Lin MarkEVP and CFO | Option exercise · 10b5-1 plan | M | — 3,164 sh | Jan 6, 2026 traded Jan 2, 2026 |